Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Net Cash Flow (2021 - 2025)

Medicinova (MNOV) has disclosed Net Cash Flow for 7 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow changed N/A to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.9 million, a N/A change, with the full-year FY2025 number at -$9.6 million, up 10.1% from a year prior.
  • Net Cash Flow was -$1.1 million for Q4 2025 at Medicinova, up from -$3.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $36.8 million in Q1 2023 to a low of -$3.9 million in Q1 2024.
  • A 5-year average of $1.9 million and a median of -$2.2 million in 2023 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: tumbled 122.95% in 2022, then skyrocketed 1085.72% in 2023.
  • Medicinova's Net Cash Flow stood at -$3.6 million in 2021, then decreased by 3.56% to -$3.7 million in 2022, then surged by 86.62% to -$499038.0 in 2023, then crashed by 307.16% to -$2.0 million in 2024, then skyrocketed by 45.81% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Net Cash Flow are -$1.1 million (Q4 2025), -$3.8 million (Q1 2025), and -$2.0 million (Q3 2024).